Search This Blog

Thursday, February 9, 2023

Raymond James, Oppenheimer cut Viking targets

 

Raymond James Adjusts Price Target on Viking Therapeutics to $12 From $11, Maintains Outperform Rating


Oppenheimer Adjusts Viking Therapeutics' Price Target to $17 From $15, Maintains Outperform Rating


Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)